Effects of tolvaptan on renal function in chronic kidney disease patients with volume overload

BACKGROUND: Fluid overload in chronic kidney disease (CKD) is generally controlled by diuretics, with potentially harmful effects on renal function. The efficacy of tolvaptan, a vasopressin V2-receptor antagonist and aquaretic, has not been evaluated for fluid control in CKD with reduced renal funct...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Shunji, Hanafusa, Norio, Kubota, Kenji, Tsuchiya, Ken, Nitta, Kosaku
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103308/
https://www.ncbi.nlm.nih.gov/pubmed/30147354
http://dx.doi.org/10.2147/IJNRD.S167694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103308/
https://www.ncbi.nlm.nih.gov/pubmed/30147354
http://dx.doi.org/10.2147/IJNRD.S167694

Ejemplares similares